NovaResp Technologies

The future of predictive and personalized lung health

[BetaKit @BetaKit]

.@novaresp is revolutionizing sleep apnea care by using AI to predict breathing events before they happen. By leveraging @ICTC_CTIC’s WIL Digital program, they’ve engaged 34 student placements to build a high-tech talent pipeline.

https://t.co/3weg0e4OOc

[NovaResp Technologies @novaresp]

Our CEO, @hamed_hanafi quoted in this article: “with cMAP® patients would feel the benefits and commit to longer term use of their #cpap devices”

[HME News @HME_News]

🚨In HME Newsbreak, hitting your inbox at 3:

😴@novaresp is conducting clinical trials for cMAP, its software platform that uses AI & ML to predict & prevent episodes of sleep apnea, & it expects to make the tech available to device manufacturers soon.

🔗https://t.co/SjCQ2kZGCF

[Halifax Chamber @halifaxchamber]

Meet @novaresp, a finalist for the 2025 Halifax Business Awards in the Innovative Business of the Year category.

Join us in supporting and cheering on the champions of our business community at the Awards on Thursday, January 23, 2025!

Register at: https://t.co/0Z6FIC3jX6

[Nova Scotia Health Innovation Hub @NSHealthHub]

Congratulations to the nominees of the Discovery Centre's 22nd annual Discovery Awards! A special shoutout to Nova Scotia Health Innovation Hub partner @novaresp 👏

[LSI - Life Science Intelligence™ @lsintelligence]

@novaresp (#LSIEurope24 Innovator) has developed a patented, #AI-enabled software compatible with any positive airway pressure (PAP) machine to dramatically improve comfort and adherence to therapy for obstructive sleep apnea (OSA) patients.

It is estimated that 1 billion people are affected by Obstructive Sleep Apnea (OSA) with 80% undiagnosed. Continuous Positive Airway Pressure (CPAP) therapy is the gold standard and first-line therapy for treating OSA, but adherence to treatment remains low due to discomfort.

The company's platform software, cMAP™, uses artificial intelligence and machine learning to predict and prevent individual episodes of apnea before they would occur. As a result, personalized therapy can be delivered via PAP machines at a substantially lower, more comfortable air pressure levels, ensuring a significantly better patient experience and adherence to therapy.

#NovaResp has achieved many recent milestones including:

-Closed a $2M Seed Plus funding round led by Concrete Ventures with participation from Invest Nova Scotia, alongside several angel investors (January 2023)
-Raised a $3M Seed Extension Round to Support Clinical Testing (May 2024)
-Announced the appointment of Raj Sodhi, a well-respected health technology thought leader, to its board of directors (August 2023)
-Completed a successful first-in-human trial in 2022, and spent 2023 further developing its cMAP™ algorithm to be compatible with any PAP machine.
-Will be conducting two large trials in 2024 to bring its game changing algorithm to CPAP manufacturers and DMEs later this year.

Want to learn more about NovaResp? Visit our website to watch Hamed Hanafi’s full presentation from LSI USA ‘24 - available on our website and YouTube channel.

You can also meet with Hamed Hanafi, CEO of NovaResp at LSI Europe ‘24 this September 16th-20th in Sintra, Portugal.

[Sleep Review @SleepReview]

.@novaresp Clinches $3M to Enhance AI-Driven #CPAP Software / The funding will support clinical testing of NovaResp’s cMAP software, which aims to provide personalized, low-pressure CPAP by predicting apnea events during #sleep. #AI
https://t.co/2db6AE8PeC

@hamed_hanafi

[NovaResp Technologies @novaresp]

@hamed_hanafi

[LSI - Life Science Intelligence™ @lsintelligence]

In a galaxy not so far away, the LSI Alumni are reaching for the stars with another week of incredible milestones 🌌 ☄️

Here's the full recap ⬇
https://t.co/RlYV8IsOcs

[LSI - Life Science Intelligence™ @lsintelligence]

NovaResp (#LSIUSA24 Innovator) has developed an AI-enabled software compatible with any positive airway pressure machine to dramatically improve comfort and adherence for obstructive sleep apnea patients.

CEO, Hamed Hanafi, has been selected to present NovaResp at LSI USA ‘24.

[Volta @voltaeffect]

@novaresp is being presented by CEO Hamed Hanafi now. NovaRest brings AI and personalized therapy to Obstructive Sleep Apnea (OSA) patients. #Volta #InvestmentDay

[Hamed Hanafi @hamed_hanafi]

ACOA has been extremely supportive of companies like @novaresp. As a result of such federal and provincial support (alongside multiple other organizations), our life sciences section is blossoming. Great future ahead!

[ACOA Canada @ACOACanada]

ACOA is supporting #Halifax life sciences companies @AdaptiivCo, Daxsonics Ultrasound, @novaresp, Sparrow Acoustics, @allumiqs and @bline_analytics in their efforts to grow their businesses and address complex medical challenges facing Canadians. 👩‍🔬 🔬🧪

https://t.co/QqOiQ07YnW

[Mayor Andy Fillmore @AndyFillmoreHFX]

🧵 Today in #Halifax I announced nearly $3 million in federal support for Atlantic Canadian life sciences companies.

These companies are embracing innovation & developing new solutions for some of our most pressing medical issues.

Details: https://t.co/QwVSIhgL4P

[NovaResp Technologies @novaresp]

We are attending #ERSCongress in Milan to meet with #sleep and #respiratory KOLs and to present our groundbreaking work in the session titled: “New insights in positive airway pressure therapy”.

Come see us tomorrow in the PS-5 poster area

[LSI - Life Science Intelligence™ @lsintelligence]

Riding the digital wave or just drifting? 🌊 🚣

Discover the reality in our newest panel at #LSIEurope23: “Data-driven Business Models for Medical Device Innovators: Future or Pipe Dream?”

[Entrevestor @entrevestor]

Halifax #medtech startup @novaresp , whose technology helps to manage sleep apnea, has added SaaS veteran Raj Sodhi to its board of directors. https://t.co/eu9Xpb1wVg

[Katheleen Eva @KatheleenEva1]

Great EY panel on Canadian healthcare tech market ft. @StandUpVentures founder @armonarani alongside @rocketdoctor and @novaresp

[Hamed Hanafi @hamed_hanafi]

Congratulations to Julia Paffile, first year @DalMedSchool student for winning both the ‘people’s choice award’ and ‘best presentation award’ at @research_dal.

#AI #pap #personalizedtherapy #osa

[Hamed Hanafi @hamed_hanafi]

We have started an exciting era to help patients with OSA.
#osa #sleepapnea #cpap #ai #dalproud https://t.co/JWEqcJy1wc

[Hamed Hanafi @hamed_hanafi]

Presenting our game-changing technology amongst Medtech’s leading innovators, investors and strategics at #LSIUSA23!

@novaresp will disrupt the OSA market with its patented, AI-enabled and comfortable PAP therapy.

Thanks to Consulate General of Canada in Los Angles and TCS.

[NovaResp Technologies @novaresp]

NovaResp AI-Enabled CPAP Gets Closer to Launch After $2M Seed Plus Round https://t.co/Z20zpt5hQU